Goserelin and preservation of ovarian function among breast cancer patients treated with adjuvant cytotoxic chemotherapy: results from a randomised trial.

被引：0
|
作者：
Sverrisdottir, A.
Nystedt, M.
Fornander, T.
机构：
[1] Univ Hosp, Karolinska Inst, Stockholm, Sweden
[2] Landspitali Univ Hosp, Reykjavik, Iceland
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2006年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S110 / S110
页数：1
相关论文
共 50 条
  • [31] Dose-dense adjuvant chemotherapy in early breast cancer patients: Results from a randomized trial
    Venturini, M
    Del Mastro, L
    Aitini, E
    Baldini, E
    Caroti, C
    Contu, A
    Testore, F
    Brema, F
    Pronzato, P
    Cavazzini, G
    Sertoli, MR
    Canavese, G
    Rosso, R
    Bruzzi, P
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (23): : 1724 - 1733
  • [32] Goserelin for ovarian protection in premenopausal breast cancer patients receiving cyclophosphamide containing chemotherapy
    Khalaf, M. I.
    Eid, S.
    Gamal, H.
    Ashraf, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S342 - S342
  • [33] Comparison of goserelin and leuprorelin for ovarian protection during chemotherapy in young patients with breast cancer
    Kim, Sung Eun
    Kim, Won-Ji
    Choi, DooSeok
    Lee, Dong-Yun
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 198 (02) : 231 - 237
  • [34] Preoperative adjuvant chemotherapy can eradicate micrometastases from bone marrow in patients with gastric cancer - Results of randomized trial.
    Popiela, T
    Kulig, J
    Szczepanik, A
    Kolodziejczyk, P
    Czupryna, A
    Gurda-Duda, A
    Pituch-Noworolska, A
    Drabik, G
    Siedlar, M
    Stachura, J
    Zembala, M
    GASTROENTEROLOGY, 2005, 128 (04) : A292 - A292
  • [35] Gonadotropin-Releasing Hormone Agonist for Preservation of Ovarian Function During (Neo)Adjuvant Chemotherapy for Breast Cancer
    Blumenfeld, Zeev
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3310 - 3310
  • [36] Maintenance of dose intensity in adjuvant chemotherapy of breast cancer in patients treated outside a clinical trial -: Results of a retrospective study
    Jackisch, C
    Jaber, M
    Burkamp, U
    Rody, A
    Rösel, S
    Raab, G
    Koch, OM
    Dame, W
    Gropp, C
    Gleumes, L
    Eiermann, W
    Schneider, HPG
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2003, 63 (04) : 333 - 341
  • [37] Comparison of goserelin and leuprorelin for ovarian protection during chemotherapy in young patients with breast cancer
    Sung Eun Kim
    Won-Ji Kim
    DooSeok Choi
    Dong-Yun Lee
    Breast Cancer Research and Treatment, 2023, 198 : 231 - 237
  • [38] Randomized Trial Using Gonadotropin-Releasing Hormone Agonist Triptorelin for the Preservation of Ovarian Function During (Neo)Adjuvant Chemotherapy for Breast Cancer
    Munster, Pamela N.
    Moore, Amy P.
    Ismail-Khan, Roohi
    Cox, Charles E.
    Lacevic, Mensura
    Gross-King, Margaret
    Xu, Ping
    Carter, W. Bradford
    Minton, Susan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05) : 533 - 538
  • [39] Ovarian function recovery in breast cancer patients receiving adjuvant anastrozole treatment: updated results from the phase 3 DATA trial
    Lammers, Senna W. M.
    Geurts, Sandra M. E.
    Hermans, Karlijn E. P. E.
    van Hellemond, Irene E. G.
    Swinkels, Astrid C. P.
    Smorenburg, Carolien H.
    van der Sangen, Maurice J. C.
    Kroep, Judith R.
    Honkoop, Aafke H.
    van den Berkmortel, Franchette W. P. J.
    de Roos, Wilfred K.
    Imholz, Alexander L. T.
    Vriens, Ingeborg J. H.
    Tjan-Heijnen, Vivianne C. G.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, : 179 - 192
  • [40] EFFICACY AND SAFETY OF GINKGO BILOBA FOR COGNITIVE FUNCTION AND FATIGUE IN BREAST CANCER PATIENTS UNDERGOING ADJUVANT CHEMOTHERAPY: A RANDOMISED, CONTROLLED TRIAL
    Dhillon, Haryana
    McLachlan, Andrew
    Renton, Corrinne
    Clarke, Stephen J.
    Boyle, Fran
    Vardy, Janette
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 156 - 156
12345